Name | trifluridine |
---|---|
Synonyms |
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxyméthyl)tétrahydrofuran-2-yl]-5-(trifluorométhyl)pyrimidine-2,4(1H,3H)-dione
Viroptic α,α,α-Trifluorothymidine 2'-Deoxy-5-(trifluoromethyl)uridine UNII-RMW9V5RW38 Trifluorothymidine 1-(2-Deoxy-β-D-glycero-pentofuranosyl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione Trifluridine 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione EINECS 200-722-8 1-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(trifluormethyl)pyrimidin-2,4(1H,3H)-dion 2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-β-D-ribofuranosyl)-5-(trifluoromethyl)- 2,4(1H,3H)-pyrimidinedione, 1-(2-deoxy-β-D-glycero-pentofuranosyl)-5-(trifluoromethyl)- 2'-Deoxy-5-trifluoromethyluridine Virophta Uridine, 2'-deoxy-5-(trifluoromethyl)- a,a,a-Trifluorothymidine MFCD00006534 |
Description | Trifluridine is an irreversible thymidylate synthase inhibitor, and thereby suppresses DNA synthesis. Trifluridine is an antiviral drug for herpes simplex virus (HSV) infection. |
---|---|
Related Catalog | |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Melting Point | 190-193 °C(lit.) |
Molecular Formula | C10H11F3N2O5 |
Molecular Weight | 296.200 |
Exact Mass | 296.062012 |
PSA | 104.55000 |
LogP | 0.07 |
Index of Refraction | 1.534 |
Storage condition | −20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS07, GHS08 |
---|---|
Signal Word | Warning |
Hazard Statements | H302 + H312 + H332-H351 |
Precautionary Statements | P261-P280-P301 + P312 + P330 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi:Irritant |
Risk Phrases | R20/21/22;R40 |
Safety Phrases | S22-S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | XP2087500 |
Precursor 8 | |
---|---|
DownStream 2 | |